InvestorsHub Logo
Followers 3183
Posts 208744
Boards Moderated 2
Alias Born 02/04/2004

Re: cysonic post# 38168

Friday, 12/07/2018 1:10:17 PM

Friday, December 07, 2018 1:10:17 PM

Post# of 38634

In any case, the Nasdaq deadline on January 10 puts massive pressure on Odidi to agree to a deal. Without a Nasdaq listing, he will never be able to make millions in financing again. That would be the end of his story.



And sadly Purdue knows this too...so imo Purdue's not gonna save them...if anything Purdue will laugh at them because they know PODRAS is nothing but a speculative dream at this point that IPCI has no chance of advancing and no chance of securing any large R&D partner on.

I would love for your thoughts to be right and my negative opinion to be wrong...but January 10th is right around the corner already and this company continues spiraling down into pos-land oblivion...if there was any real hope or miracle savior deal coming from Purdue or anyone else the share price erosion wouldn't be continuing...because sadly the market always knows.

They couldn't even get all the HAP results posted by year end let alone refile their rexista nda candidate. So again we're gonna see them miss resubmitting rexista this year thus missing another self-imposed projected timeline.

Their Rexista adcom disaster was a year and a half ago...and despite raising millions of dollars from dilutive financing...they still aren't even in a position of resubmitting Rexista to the FDA because the poor planning and ineptitude from this mgmt. team continues unabated. There's no excuse for them already taking a full year and a half to even try to get rexista HAP studies/results completed let alone then resubmitting rexista to the fda...but IPCI always fails miserably at remotely timely execution of anything they try to accomplish.




Never buy or sell based on my posts! My posts are just my opinion!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y